Krystal Biotech (KRYS) – Research Analysts’ Recent Ratings Changes
Krystal Biotech (NASDAQ: KRYS) has recently received a number of price target changes and ratings updates: 5/7/2025 – Krystal Biotech had its price target lowered by analysts at Guggenheim from $195.00 to $189.00. They now have a “buy” rating on the stock. 5/7/2025 – Krystal Biotech had its “buy” rating reaffirmed by analysts at Chardan […]
12 May 17:17 · The Cerbat Gem